Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Aktuell durch Fördergeber bewilligte Forschungsprojekte:

Diagnostic Tool for Sepsis Detection
Projektleitung: Krause Robert
Laufzeit: 01.04.2023 - 31.12.2023
Geldgeber: acib GmbH
Österreichische Forschungsförderungsgesellschaft mbH (FFG)

STEUERUNG MULTIMODALER THERAPIEN GEGEN MINIMALE RESTERKRANKUNGEN DURCH FLÜSSIGBIOPSIEN
Projektleitung: Heitzer Ellen
Laufzeit: 01.05.2023 - 30.04.2028
Geldgeber: Europäische Kommission

> Weitere neue Projekte

Die aktuellsten Publikationen in "Top-Journalen" (Top 20 % Impact Ranking):

25.05.2023:

Fischer, U; Koga, M; Strbian, D; Branca, M; Abend, S; Trelle, S; Paciaroni, M; Thomalla, G; Michel, P; Nedeltchev, K; Bonati, LH; Ntaios, G; Gattringer, T; Sandset, EC; Kelly, P; Lemmens, R; Sylaja, PN; Aguiar, de, Sousa, D; Bornstein, NM; Gdovinova, Z; Yoshimoto, T; Tiainen, M; Thomas, H; Krishnan, M; Shim, GC; Gumbinger, C; Vehoff, J; Zhang, L; Matsuzono, K; Kristoffersen, E; Desfontaines, P; Vanacker, P; Alonso, A; Yakushiji, Y; Kulyk, C; Hemelsoet, D; Poli, S; Paiva, Nunes, A; Caracciolo, N; Slade, P; Demeestere, J; Salerno, A; Kneihsl, M; Kahles, T; Giudici, D; Tanaka, K; Räty, S; Hidalgo, R; Werring, DJ; Göldlin, M; Arnold, M; Ferrari, C; Beyeler, S; Fung, C; Weder, BJ; Tatlisumak, T; Fenzl, S; Rezny-Kasprzak, B; Hakim, A; Salanti, G; Bassetti, C; Gralla, J; Seiffge, DJ; Horvath, T; Dawson, J Early versus Later Anticoagulation for Stroke with Atrial Fibrillation.
N Engl J Med. 2023; Doi: 10.1056/NEJMoa2303048
PubMed FullText FullText_MUG

 

25.05.2023:

Abdel-Aziz, MI; Thorsen, J; Hashimoto, S; Vijverberg, SJH; Neerincx, AH; Brinkman, P; van, Aalderen, W; Stokholm, J; Rasmussen, MA; Roggenbuck-Wedemeyer, M; Vissing, NH; Mortensen, MS; Brejnrod, AD; Fleming, LJ; Murray, CS; Fowler, SJ; Frey, U; Bush, A; Singer, F; Hedlin, G; Nordlund, B; Shaw, DE; Chung, KF; Adcock, IM; Djukanovic, R; Auffray, C; Bansal, AT; Sousa, AR; Wagers, SS; Chawes, BL; Bønnelykke, K; Sørensen, SJ; Kraneveld, AD; Sterk, PJ; Roberts, G; Bisgaard, H; Maitland-van, der, Zee, AH Oropharyngeal Microbiota Clusters in Children with Asthma/Wheeze Associate with Allergy, Blood Transcriptomic Immune Pathways and Exacerbations Risk.
Am J Respir Crit Care Med. 2023; Doi: 10.1164/rccm.202211-2107OC
PubMed FullText FullText_MUG

 

24.05.2023:

van, Poppel, MNM; Damm, P; Mathiesen, ER; Ringholm, L; Zhang, C; Desoye, G Is the Biphasic Effect of Diabetes and Obesity on Fetal Growth a Risk Factor for Childhood Obesity?
Diabetes Care. 2023; 46(6):1124-1131 Doi: 10.2337/dc22-2409
PubMed FullText FullText_MUG

 

24.05.2023:

Apollonio, B; Spada, F; Petrov, N; Cozzetto, D; Papazoglou, D; Jarvis, P; Kannambath, S; Terranova-Barberio, M; Amini, RM; Enblad, G; Graham, CE; Benjamin, R; Phillips, EH; Ellis, RJ; Nuamah, R; Saqi, M; Calado, DP; Rosenquist, R; Sutton, LA; Salisbury, JR; Zacharioudakis, G; Vardi, A; Hagner, PR; Gandhi, AK; Bacac, M; Claus, C; Umana, P; Jarrett, RF; Klein, C; Deutsch, AJ; Ramsay, AG Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma.
J Clin Invest. 2023; Doi: 10.1172/JCI166070
PubMed FullText FullText_MUG

 

24.05.2023:

Frede, N; Rieger, E; Lorenzetti, R; Venhoff, AC; Kanne, AM; Finzel, S; Jandova, I; Glaser, C; Thiel, J; Voll, RE; Venhoff, N Sleep behaviour differs in women and men with psoriatic arthritis and axial spondyloarthritis with impact on quality of life and depressive symptoms.
RMD Open. 2023; 9(2): Doi: 10.1136/rmdopen-2022-002912 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

24.05.2023:

Gollmer, J; Zirlik, A Identifying leukocyte phenotypes by scRNA-seq to predict cardiovascular risk.
Nat Rev Cardiol. 2023; Doi: 10.1038/s41569-023-00891-1
PubMed FullText FullText_MUG

 

24.05.2023:

Sadoghi, B; Stary, G; Wolf, P Syphilis.
J Dtsch Dermatol Ges. 2023; 21(5):504-517 Doi: 10.1111/ddg.14999
PubMed FullText FullText_MUG

 

24.05.2023:

Jandl, K; Radic, N; Zeder, K; Kovacs, G; Kwapiszewska, G Pulmonary vascular fibrosis in pulmonary hypertension - The role of the extracellular matrix as a therapeutic target.
Pharmacol Ther. 2023; 108438 Doi: 10.1016/j.pharmthera.2023.108438
PubMed FullText FullText_MUG

 

22.05.2023:

Egli-Spichtig, D; Hamid, AK; Arroyo, EMP; Ketteler, M; Wiecek, A; Rosenkranz, AR; Pasch, A; Lorenz, H; Hellmann, B; Karus, M; Ammer, R; Rubio-Aliaga, I; Wagner, CA Intact FGF23 predicts serum phosphate improvement after combined nicotinamide and phosphate binder treatment in hemodialysis patients
CLIN KIDNEY J. 2023; Doi: 10.1093/ckj/sfad040
Web of Science FullText FullText_MUG

 

22.05.2023:

Frohlich, E; Steinritz, D Editorial: Case reports in predictive toxicology: 2022
FRONT PHARMACOL. 2023; 14: 1180949 Doi: 10.3389/fphar.2023.1180949
Web of Science PubMed FullText FullText_MUG

 

22.05.2023:

Mehta, PP; Frohlich, E; Khan, R; Parihar, A; Kumar, CMS Editorial: Advances in orally inhaled and nasal drug products (OINDPs)
FRONT PHARMACOL. 2023; 14: 1185609 Doi: 10.3389/fphar.2023.1185609
Web of Science PubMed FullText FullText_MUG

 

22.05.2023:

Cibula, D; Raspollini, MR; Planchamp, F; Centeno, C; Chargari, C; Felix, A; Fischerova, D; Jahnn-Kuch, D; Joly, F; Kohler, C; Lax, S; Lorusso, D; Mahantshetty, U; Mathevet, P; Naik, R; Nout, RA; Oaknin, A; Peccatori, F; Persson, J; Querleu, D; Bernabe, SR; Schmid, MP; Stepanyan, A; Svintsitskyi, V; Tamussino, K; Zapardiel, I; Lindegaard, J ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023*
INT J GYNECOL CANCER. 2023; Doi: 10.1136/ijgc-2023-004429
Web of Science PubMed FullText FullText_MUG

 

22.05.2023:

Hoehlschen, J; Hofreither, D; Tomin, T; Birner-Gruenberger, R Redox-driven cardioprotective effects of sodium-glucose co-transporter-2 inhibitors: comparative review
CARDIOVASC DIABETOL. 2023; 22(1): 101 Doi: 10.1186/s12933-023-01822-7
Web of Science PubMed FullText FullText_MUG

 

22.05.2023:

Bianco, V; Korbelius, M; Vujic, N; Akhmetshina, A; Amor, M; Kolb, D; Pirchheim, A; Bradic, I; Kuentzel, KB; Buerger, M; Schauer, S; Phan, HTT; Bulfon, D; Hoefler, G; Zimmermann, R; Kratky, D Impact of (intestinal) LAL deficiency on lipid metabolism and macrophage infiltration.
Mol Metab. 2023; 73:101737 Doi: 10.1016/j.molmet.2023.101737
PubMed FullText FullText_MUG

 

22.05.2023:

Sturm, GJ; Boni, E; Antolín-Amérigo, D; Bilò, MB; Breynaert, C; Fassio, F; Spriggs, K; Vega, A; Ricciardi, L; Arzt-Gradwohl, L; Hemmer, W Allergy to stings and bites from rare or locally important arthropods: worldwide distribution, available diagnostics, and treatment.
Allergy. 2023; Doi: 10.1111/all.15769
PubMed FullText FullText_MUG

 

> Weitere aktuelle Publikationen in Top-Journals

Distribution of Med Uni Graz affiliated publications by field-normalized Journal Impact Factor (JIFnorm)

Med Uni Graz publications¹ were assigned quintiles according to the normalized² Clarivate’s Journal Impact Factor of the journal at the time of publication.

Proportional Distribution: The color-coded columns show the distribution by JIFnorm-quintiles, while the left vertical axis indicates the proportion relative to the total articles published in a given year. The red line shows the total number of articles published each year (right vertical axis).

Example 1: Around 40% of the over 500 articles with Med Uni Graz affiliation published in 2019 had a normalized JIF > 0.8 (QU1).
Example 2: The proportion of articles published in journals with a normalized JIF < 0.4 (QU4 and QU5) has remained under 20% since 2010.

Absolute Impact: The sum of the normalized JIFs for all published articles in a given year, color-coded according to the respective quintile.

¹ This analysis considered only publications categorized as full papers/original articles.

² IFnorm = (number of journals in WoS category - ranking of journal + 1) / number of journals in WoS category. An IFnorm of 0.8 means that 20% of the journals in this subject category have a higher IF than the respective journal. The highest possible IFnorm is 1, which means that this journal currently has the highest IF in this subject category.